Syntax Research’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Syntax Research's AMGN Position: Q1 2026 in Review
Syntax Research held its Amgen (AMGN) position steady in Q1 2026 at 237 shares worth $83.4K. The position accounts for 0.05% of the portfolio, ranked #84.
Syntax Research first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Syntax Research held 237 shares of Amgen worth $83.4K as of Q1 2026.
- Syntax Research left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.05% of Syntax Research's portfolio in Q1 2026, its #84 holding.
- Syntax Research first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Syntax Research's 13F filing for Q1 2026, filed 24 Apr 2026.